Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare costs ...

Home May 31, 2017
Home
News | Atrial Fibrillation

May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) ...

Home May 30, 2017
Home
News | Pharmaceuticals

May 26, 2017 — Statins are associated with improved heart structure and function, according to research presented at ...

Home May 26, 2017
Home
Feature | Pharmaceuticals

May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal ...

Home May 16, 2017
Home
News | Stroke

May 12, 2017 — More than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) were observed to ...

Home May 12, 2017
Home
anticoagulants increase dementia risks
Feature | Antiplatelet and Anticoagulation Therapies

May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for atri ...

Home May 12, 2017
Home
Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)
Feature | Point of Care Testing | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on ...

Home May 05, 2017
Home
News | Pharmaceuticals

May 5, 2017 — A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing ...

Home May 05, 2017
Home
An electrophysiology EP ablation procedure to treat a heart arrhythmia
Feature | HRS

May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 ...

Home May 16, 2017
Home
News | Pharmaceuticals

April 3, 2017 — There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes ...

Home April 03, 2017
Home
Ablation procedure, EP lab, Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation
Feature | Atrial Fibrillation

March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...

Home March 29, 2017
Home
News | Pharmaceuticals

March 29, 2017 — Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good ...

Home March 29, 2017
Home
News | Chronic Total Occlusion (CTO) | Dave Fornell

March 29, 2017 — In patients with a complete, persistent arterial blockage, medication alone was found to be equal to pe ...

Home March 29, 2017
Home
News | Pharmaceuticals

March 28, 2017 — When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not ...

Home March 28, 2017
Home
Subscribe Now